Literature DB >> 16790256

Non-identical patterns of proviral insertions around host transcription units in lymphomas induced by different strains of murine leukemia virus.

Javier Martín-Hernández1, Annette Balle Sørensen, Finn Skou Pedersen.   

Abstract

In a small sample of 57 retrovirus integration sites (RISs) isolated from 23 end-stage lymphomas induced in NMRI mice by the B-lymphotropic Akv wt or an enhancer mutant hereof, Akv1-99, we identified 14 novel RISs and defined 9 novel CISs (common insertion sites). Moreover, when comparing with RISs from tumors induced by the T-lymphomagenic SL3-3, we observed that SL3-3 targets RefSeq promoter regions with a significantly higher frequency than Akv/Akv1-99 and in an orientation-dependent way. Altogether, our results strongly emphasize the importance of host genetic background and virus type for retroviral insertion mutagenesis screens and suggest that different types of MLV may favor specific genomic regions and orientations in order exert optimal effect on target gene expression during lymphoma induction and development.

Entities:  

Mesh:

Year:  2006        PMID: 16790256     DOI: 10.1016/j.virol.2006.05.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma.

Authors:  Keith C Weiser; Bin Liu; Gwenn M Hansen; Darlene Skapura; Kathryn E Hentges; Sujatha Yarlagadda; Herbert C Morse Iii; Monica J Justice
Journal:  Mamm Genome       Date:  2007-10-10       Impact factor: 2.957

2.  Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.

Authors:  Annette Balle Sørensen; Anders H Lund; Sandra Kunder; Leticia Quintanilla-Martinez; Jörg Schmidt; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Retrovirology       Date:  2007-07-06       Impact factor: 4.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.